跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
PIPTAZ-AFT POWDER FOR SOLUTION FOR INJECTION 4.5G/VIAL - HSA Drug Approval Details
Approvals
/
HSA
/
PIPTAZ-AFT POWDER FOR SOLUTION FOR INJECTION 4.5G/VIAL
Approved
THERAPEUTIC
PIPTAZ-AFT POWDER FOR SOLUTION FOR INJECTION 4.5G/VIAL
SHANDONG ANXIN PHARMACEUTICAL CO., LTD. (WORKSHOP 2100) (CHINA)
🇸🇬 Health Sciences Authority
Approval Date
May 11, 2018
Approval ID
0469c177ca77b417
Company
SHANDONG ANXIN PHARMACEUTICAL CO., LTD. (WORKSHOP 2100) (CHINA)
Type
Therapeutic
Approval Details
Approval Id
0469c177ca77b417
Drug Name
PIPTAZ-AFT POWDER FOR SOLUTION FOR INJECTION 4.5G/VIAL
Product Name
PIPTAZ-AFT POWDER FOR SOLUTION FOR INJECTION 4.5G/VIAL
Approval Number
SIN15482P
Approval Date
2018-05-11
Registrant
APEX PHARMA MARKETING PTE. LTD.
Licence Holder
APEX PHARMA MARKETING PTE. LTD.
Drug Type
Therapeutic
Forensic Classification
PRESCRIPTION ONLY MEDICINES
Dosage Form
INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Route Of Administration
INTRAVENOUS
Atc Code
J01CR05
Atc Item Name
piperacillin and beta-lactamase inhibitor
Pharma Manufacturer Name
APEX PHARMA MARKETING PTE. LTD.
Company Detail Path
/organization/apex-pharma-marketing-pte-ltd
Active Ingredients
Tazobactam sodium 0.537g eqv. Tazobactam
0.5g
Piperacillin sodium 4.170g eqv. Piperacillin
4g
Piperacillin sodium 4.170g eqv. Piperacillin
4g
Tazobactam sodium 0.537g eqv. Tazobactam
0.5g
Approved
Quick Info
Agency
HSA
Country
🇸🇬
Approval Date
May 11, 2018
Approval ID
0469c177ca77b417
Type
Therapeutic
Back to HSA Approvals
